ELA France and ELA International are launching Leuconnect, an online platform dedicated to help clinical research by facilitating recruitment of patients into studies and clinical trials, to help the acceleration of research on leukodystrophies in France and worldwide.
With online administration of the study and the possibility to select studies, Leuconnect will allow you to be a true actor of research.
The platform is articulated around two interfaces:
The access to Leuconnect is highly secured. All personal information is stored by a professional host (Almerys) which received credential from the French Health ministry (Ministère de la Santé) and guarantees confidentiality. Investigators are also subject to high security identification.
We invite you to discover Leuconnect now!